Phase 1b/2 Study of DPX-E7 + Cyclophosphamide in HPV-positive Cancers

Share this content:
Researchers are evaluating whether DPX-E7 vaccination is safe and will improve outcomes among patients with HPV-positive head and neck, cervical, or anal cancer.
Researchers are evaluating whether DPX-E7 vaccination is safe and will improve outcomes among patients with HPV-positive head and neck, cervical, or anal cancer.

Title: A Phase Ib/II Trial To Test The Safety And Efficacy Of Vaccination With HPV16-E711-19 Nanomer For The Treatment Of Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer In HLA-A*02 Positive Patients1

Principal Investigators: Jochen Lorch, MD, Dana-Farber Cancer Institute

Description: For this single group, phase 1b/2 trial, researchers are evaluating whether DPX-E7 vaccination is safe and will improve outcomes among patients with HPV-positive head and neck, cervical, or anal cancer.

Enrolled patients will receive DPX-E7 and low-dose cyclophosphamide; patients must be positive for HLA-A*02.

The primary outcome is the number of patients with treatment-related adverse events; secondary outcomes include overall response rate, overall survival, and progression-free survival.

For more study information, including inclusion and exclusion criteria, study locations, and contact information, visit https://clinicaltrials.gov/ct2/show/NCT02865135.

Status: This study is open and recruiting patients as of April 11, 2017.

This study is sponsored by Dana-Farber Cancer Institute in collaboration with Stand Up To Cancer.

DPX-E7 is an investigational vaccine not yet approved by the US Food and Drug Administration for the treatment of any disease.

Reference

  1. Clinicaltrials.gov. Trial to test safety and efficacy of vaccination for incurable HPV 16-related oropharyngeal, cervical and anal cancer. NCT02865135. https://clinicaltrials.gov/ct2/show/NCT02865135. Accessed April 11, 2017.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters